<DOC>
	<DOCNO>NCT00234169</DOCNO>
	<brief_summary>Hematopoietic stem cell ( HSC ) use support administration high dose chemotherapy range human cancer . For safe HSC transplantation , minimum 5 million HSC per kilogram require . HSC collect bone marrow use drug G-CSF ( filgrastim ) 'mobilize ' bone marrow bloodstream . HSC collect bloodstream use apheresis machine . Between 5 60 % patient fail mobilize minimum HSC dose require safe transplantation , trial investigate way enhance mobilization overcome problem . This trial aim determine new vitamin A derivative capable enhance HSC mobilization use conjunction G-CSF . Patients undergo two mobilization procedure . They give G-CSF alone , combination study drug plus G-CSF , stem cell collect . A comparison group patient give G-CSF alone mobilization . Stem cell collect patient trial frozen store required transplantation patient . At time , patient monitor well recover high dose chemotherapy HSC transplantation .</brief_summary>
	<brief_title>A Study Peripheral Blood Progenitor Cells Mobilisation ( PBPC ) With VTP195183 Plus Granulocyte-Colony Stimulating Factor ( G-CSF ) Compared Mobilisation With G-CSF Alone</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>1 . Age 1870 2 . Histologically proven multiple myeloma lymphoma 3 . Intent treat physician proceed high dose therapy autologous transplantation 4 . Not currently receive thalidomide ( within 1 week commence VTP195813 GCSF ) , cytotoxic agent high dose prednisolone Dexamethasone ( dose great 15 mg prednisolone equivalent per day ) 5 . Multiple myeloma patient must take regular bisphosphonate therapy 6 . Absolute neutrophil count 1.5 10 x 109/L 7 . ECOG performance status ? 2 8 . Life expectancy least 2 month 9 . Written inform consent sign patient legally authorize representative 1 . Active infection fever &gt; 38.2 degree C ( fever due B symptom lymphoma patient exclude patient ) 2 . Use within previous 30 day vitamin A preparation within last 30 day ( include oral vitamin supplement , oral retinoids acne skin disorder , bexarotene , topical vitamin A preparation ) 3 . Pregnancy breast feed . Women childbearing potential , admitted trial must take adequate measure prevent conception ( least two different form contraception study least one month completion study drug ) undergo pregnancy test 4 . Significant nonmalignant disease include HIV infection , uncontrolled hypertension ( diastolic blood pressure &gt; 115 mmHg ) , unstable angina 5 . Known allergy E.coliderived product 6 . Current treatment tetracycline antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Lymphoma</keyword>
</DOC>